Lemaitre Vascular INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
David B Roberts, President and Director and a Director of Lemaitre Vascular Inc, reported multiple transactions in common stock on September 3, 2026.
NASDAQ
Joseph P Pellegrino Jr, a Director of Lemaitre Vascular Inc, reported multiple transactions in common stock on September 3, 2026.
NASDAQ
Lawrence J Jasinski, a Director of Lemaitre Vascular Inc, reported multiple transactions in common stock on September 3, 2026.
NASDAQ
Martha Shadan, a Director of Lemaitre Vascular Inc, reported multiple transactions in common stock on September 3, 2026.
NASDAQ
John James O'Connor, a Director of Lemaitre Vascular Inc, reported multiple transactions in common stock on September 3, 2026.
NASDAQ
Dorian Paul Leblanc, Chief Financial Officer of Lemaitre Vascular Inc, reported multiple transactions in common stock on September 3, 2026.
NASDAQ
George W Lemaitre, Chairman and CEO and a Director of Lemaitre Vascular Inc, reported multiple transactions in common stock on September 3, 2026.
NASDAQ
Trent G Kamke, Senior V. P., Operations of Lemaitre Vascular Inc, reported multiple transactions in common stock on September 3, 2026.
NASDAQ
John A Roush, a Director of Lemaitre Vascular Inc, reported multiple transactions in common stock on September 3, 2026.
NASDAQ
Director Lawrence J. Jasinski reported the acquisition of dividend equivalent rights on existing equity awards.
NASDAQ
Director John James O'Connor reported the accrual of dividend equivalent rights related to existing equity awards.
NASDAQ
Director John A. Roush reported the accrual of dividend equivalent rights on existing equity awards.
NASDAQ
Director Martha Shadan of LeMaitre Vascular, Inc. reported the acquisition of dividend equivalent rights related to existing equity awards.
NASDAQ
Director Joseph P. Pellegrino Jr. acquired additional dividend equivalent rights related to existing equity awards.
NASDAQ
CFO Dorian Paul LeBlanc acquired additional dividend equivalent rights related to existing restricted stock unit awards.
NASDAQ
President and Director David B. Roberts reported the accrual of dividend equivalent rights on existing equity awards.
NASDAQ
Senior VP Trent G. Kamke reported the accrual of dividend equivalent rights related to existing equity awards.
NASDAQ
Chairman and CEO George W. LeMaitre transferred 11,974 shares of common stock to an irrevocable family trust.
NASDAQ
Chairman and CEO George W. LeMaitre sold 46,481 shares of common stock over two days in May 2026.
NASDAQ
Lemaitre Vascular Senior VP of Operations, Trent G. Kamke, sold 2,928 shares of common stock for approximately $107 per share under a pre-arranged trading plan.
NASDAQ
Director Bridget A. Ross reported transactions involving Lematire Vascular Inc. common stock, including option exercises and share disposals.
NASDAQ
Director Lawrence J. Jasinski reported transactions involving Lemaître Vascular Inc. common stock, including option exercises and a sale.
NASDAQ
Director Joseph P. Pellegrino Jr. exercised options to acquire 2,941 shares of LeMaitre Vascular common stock.
NASDAQ
Lemaitre Vascular Director Martha Shadan reported the accrual of dividend equivalent rights tied to previously granted restricted stock and performance share units.
NASDAQ
Lemaitre Vascular Director Bridget A. Ross reported the acquisition of dividend equivalent rights tied to her restricted stock and performance share units.
NASDAQ
Director John James O'Connor of Lemaitre Vascular Inc. reported the accrual of dividend equivalent rights tied to existing equity awards.
NASDAQ
Lemaitre Vascular Director John A. Roush reported the acquisition of dividend equivalent rights tied to previously granted equity awards.
NASDAQ
Lemaitre Vascular Director Lawrence J. Jasinski reported the accrual of dividend equivalent rights tied to his restricted and performance stock unit awards.
NASDAQ
Joseph P. Pellegrino JR, a Director at LEMAITRE VASCULAR INC, reported the acquisition of dividend equivalent rights tied to various equity awards.
NASDAQ
Lemaitre Vascular President and Director David B. Roberts acquired additional dividend equivalent rights tied to his equity awards.